Bellis Egészségtár Ltd.

What Bellis Egészségtár Ltd. does

Bellis Egészségtár Ltd. (legal name: Bellis Egészségtár Kft.) is a privately held, Budapest-based B2B wholesale distributor of pharmaceuticals and healthcare products serving the Hungarian market. The company operates two distinct business units: a Non-Pharma division that distributes medical aids (gyógyászati segédeszköz/GYSE) and health products with what it claims is the broadest portfolio in Hungary, and a Pharma division that supplies pharmacies lacking complete drug assortments via a nationwide delivery footprint. With 18 employees and more than 450 supplier partnerships, Bellis maintains over 15,000 active product items in continuous availability, positioning itself as the primary choice among non-full-spectrum pharmaceutical wholesalers for pharmacy customers.

Revenue is generated through wholesale transaction margins on goods supplied to two primary retail-partner segments: pharmacies and medical device retailers. The company serves these customers through a dedicated webshop (webshop.bellis.hu), an authenticated partner portal, monthly promotional newsletters (Hírlevél), and toll-free customer service (06-80-203-235). Commercial activity is reinforced by two exclusive partner programs — GYSEpont Partnerprogram for medical device partners and Vitalitáspont loyalty program for pharmacy partners — which provide marketing support, promotional reach, and stickiness. The underlying technology stack is standard B2B e-commerce infrastructure with no disclosed proprietary platform, AI/ML capabilities, or differentiated software components.

The business model is domestic-only, single-country wholesale distribution reliant on transaction-fee economics. Customers access pricing only after registration and authentication, indicating relationship-driven B2B pricing rather than transparent public pricing. The company has no disclosed parent, no funding history, no M&A activity, and no public market presence, suggesting a stable, owner-operated enterprise with limited external capital signals.

Name

Bellis Egészségtár Ltd.

Legal name

Bellis Egészségtár Kft.

Website

https://bellis.hu

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Bellis Egészségtár Ltd. is a Budapest-based B2B wholesale distributor of pharmaceuticals and medical devices, serving Hungarian pharmacies and medical device retailers through two business units with 15,000+ products sourced from 450+ suppliers.

Ownership category

akta.pro rank

Headquarters

HQ city

Budapest

HQ country

Hungary

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Wholesale Distribution - Non-Pharma: Revenue generated through wholesale distribution of medical devices and health products to GYSE (gyógyászati segédeszköz) partners across Hungary.
2. Wholesale Distribution - Pharma: Revenue from supplying pharmaceuticals to pharmacies through the Pharma sales channel, serving as the primary choice among non-full-spectrum pharmaceutical wholesalers.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Bellis Egészségtár Kft. is a B2B wholesale distributor operating two business units: Non-Pharma (medical devices and healthcare products — gyógyászati segédeszköz) and Pharma (pharmaceuticals). The company supplies pharmacy chains, independent pharmacies, and medical device retailers across Hungary through a webshop, partner portal, and direct sales, drawing on 450+ supplier partnerships to offer 15,000+ active SKUs.

Product overview

Bellis Egészségtár Ltd. operates as a B2B pharmaceutical and healthcare products wholesale distributor with two distinct business units: the Non-Pharma division (medical aids and healthcare products) and the Pharma division (pharmaceutical wholesale). The company connects over 450 supplier partners with pharmacy and medical device retailer customers through a portfolio exceeding 15,000 active product items. Supporting the core wholesale operations, the company offers the GYSEpont Partnerprogram (medical device market partner program), Vitalitáspont Program (pharmacy loyalty program), Hírlevél (monthly newsletter), and WebShop (online ordering portal). The company is headquartered in Budapest, Hungary.

Differentiator

Problem solved

Functional benefit

Brands

• Vitalitáspont Program: A loyalty program for pharmacy partners providing points-based rewards and exclusive benefits.
• GYSEpont Partnerprogram

Products and services

• Bellis Non-Pharma Business Unit (Bellis Non-Pharma üzletág) Wholesale distribution of medical devices (gyógyászati segédeszköz) and other healthcare products to GYSE partners across Hungary, offering the country's widest portfolio with over 15,000 active product items from more than 450 supplier partners.
• Bellis Pharma Business Unit (Bellis Pharma üzletág) Pharmaceutical wholesale supply to pharmacies that lack a complete drug assortment, positioned as the first-choice among non-full-spectrum pharmaceutical wholesalers with nationwide Hungarian coverage.
• GYSEpont Partnerprogram Partner program unique in the Hungarian medical device market that supports GYSE partners' business activities with a selected product portfolio while strengthening supplier partners' market presence.
• Vitalitáspont Loyalty Program Points-based loyalty program available to pharmacy partners, providing rewards, exclusive promotional opportunities, and benefits to support their commercial activities.

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

18 partnerships are on record, tiered core and minor.

• BérescoreOthersPharmaceutical and health product supplier partner featured in Bellis's key partner logos.
• SanoficoreOthersGlobal pharmaceutical company listed as a key supplier partner of Bellis.
• GSK (GlaxoSmithKline)coreOthersGlobal pharmaceutical and healthcare company listed as a key supplier partner.
• Richter GedeoncoreOthersHungarian multinational pharmaceutical company listed as a key supplier partner.
• Egis PharmaceuticalscoreOthersHungarian pharmaceutical company listed as a key supplier partner.
• PfizercoreOthersGlobal pharmaceutical company listed as a key supplier partner.
• EssityminorOthersHealth and hygiene products company listed as a key supplier partner.
• WalmarkminorOthersHealth supplements company listed as a supplier partner.
• MerckcoreOthersGlobal science and technology company with pharmaceutical division listed as supplier partner.
• SandozcoreOthersGeneric pharmaceutical company listed as a key supplier partner.
• BayercoreOthersGlobal pharmaceutical and life sciences company listed as a key supplier partner.
• ReckittminorOthersConsumer health company listed as a supplier partner.
• BioextraminorOthersHealth product supplier listed as a partner.
• NovartiscoreOthersGlobal pharmaceutical company listed as a key supplier partner.
• Omega PharmaminorOthersPharmaceutical company listed as a supplier partner.
• HerbariaminorOthersHerbal/health product company listed as a supplier partner.
• KRKAminorOthersGeneric pharmaceutical company listed as a supplier partner.
• BiocominorOthersHealth product company listed as a supplier partner.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• McKesson Corporation: Global pharmaceutical distribution and healthcare services leader. Operates broad pharma distribution to pharmacies, hospitals, and manufacturers at scale; relevant as the global benchmark for pharma wholesale economics Bellis competes within.
• Alliance Healthcare (Walgreens Boots Alliance): European pharmaceutical wholesale and distribution arm of Walgreens Boots Alliance, operating pre-wholesale and distribution to pharmacies across multiple countries. Comparable in B2B pharma distribution model and IT-enabled ordering portals.
• Bunzl plc: Global distribution and outsourcing group supplying everyday essentials including healthcare and medical products. While diversified, its healthcare distribution arm mirrors Bellis's B2B wholesale supply model to pharmacy and care customers.
• Cardinal Health: Fortune-50 pharmaceutical and medical product distributor serving retail pharmacies, hospitals, and healthcare systems globally. Comparable business model with wholesale drug distribution and medical-surgical product supply.
• HARTMANN Group: Family-owned European medical products and hygiene goods manufacturer-distributor. Comparable in medical device and healthcare product wholesale supply to pharmacies and care providers across European geographies.
• Cencora (formerly AmerisourceBergen): One of the world's largest pharmaceutical solutions companies, distributing branded, specialty, and generic drugs to pharmacies, hospitals, and providers worldwide. Comparable end market and pharmaceutical supply-chain intermediary role.
• Mediq: European distributor of medical devices, healthcare products, and homecare solutions to healthcare providers and retailers. Directly comparable to Bellis's Non-Pharma (GYSE) medical device wholesale business unit in both product category and channel-to-pharmacies model.

Direct peers

• PHOENIX Group: Leading European pharmaceutical distributor operating wholesale and BENU pharmacies across multiple CEE markets including Hungary. Competes head-to-head with Bellis for pharmacy wholesale accounts and operates a similar broadline pharma + medical product portfolio.
• Hungaropharma Zrt. Hungary's largest pharmaceutical wholesaler supplying pharmacies nationwide. Direct competitor to Bellis's Pharma sales channel, with comparable B2B pharmacy distribution model and competing for the same set of independent pharmacies.

Emerging players

• Coloplast: Global medical device company focused on ostomy, continence, wound, and skin care products with European pharmacy distribution. Overlaps with Bellis's medical device portfolio category and shares dependence on pharmacy channel sales in European markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bellis-eg%C3%A9szs%C3%A9gt%C3%A1r-kft.

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bellis Egészségtár Ltd.